Novel machine learning algorithm to predict response to immunotherapy in patients with small cell and non-small cell lung cancer von Sharma, Lakshya, Choi, Sunyoung, Balaji, Vaishnavi, Joshi, Adwait, Mporas, Iosif, Shi, Jiaqi, Zhao, Yi, Tailor, Vipula, Shah, Riyaz N.H., Waters, Justin S., Adeleke, Sola Michael

Volltext

Importance of clinical decision making in precision oncology: Discordance in recommendation between next generation sequencing test vendor and molecular tumour board in India von Sirohi, Bhawna, Davis, Sissmol, R I, Anu, Suryavanshi, Moushumi, Dawood, Shaheenah S., Panda, Pankaj Kumar, Nag, Shona Milon, Das, Arunangshu, Rohatgi, Nitesh, Popat, Sanjay, Shah, Riyaz N.H., Thampy, Cherian, Parikh, Aparna Raj, Yadav, Siddhartha, Mehta, Prashant, Singh, Randeep, Mukherji, Deborah, Shilpakar, Ramila, Mullapally, Sujith Kumar, Mathew, Aju

Volltext

Treatment of recurrent or metastatic renal cell carcinoma von Shah, Riyaz NH, Ahmad, Tanya, Eisen, Tim G

Volltext

Correlation between thymidylate synthetase (TS) expression and progression-free survival (PFS) in patients receiving pemetrexed (pem) for advanced NSCLC: A prospective study von Nicolson, Marianne, Kerr, Keith M, Shah, Riyaz N.H., Potter, Vanessa, Upadhyay, Sunil, Taylor, Paul, Myrand, Scott, Nuguyen, Tuan Stevon, Das, Mayukh, Fennell, Dean Anthony

Volltext

LUX-Lung 3: A randomized, open-label, phase III study of afatinib versus pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harb... von Yang, James Chih-Hsin, Schuler, Martin H., Yamamoto, Nobuyuki, O'Byrne, Kenneth John, Hirsh, Vera, Mok, Tony, Geater, Sarayut Lucien, Orlov, Sergey V, Tsai, Chun-Ming, Boyer, Michael J., Su, Wu-Chou, Bennouna, Jaafar, Kato, Terufumi, Gorbunova, Vera, Lee, Ki Hyeong, Shah, Riyaz N.H., Massey, Dan, Lorence, Robert M., Shahidi, Mehdi, Sequist, Lecia V.

Volltext